Join
Live feed
·
INSIDERFilingvia Quantisnow
Inozyme Pharma Inc. logo

Treco Douglas A sold $52,210 worth of shares (7,523 units at $6.94) and converted options into 25,000 shares, increasing direct ownership by 548% to 20,665 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track INZY (Inozyme Pharma Inc.) and more on Quantisnow.